Shares of DocuSign Inc DOCU came under pressure last week, after the company announced plans to slash 10% of its workforce.
The latest layoff announcement sends “a negative demand signal” about the company’s growth in fiscal 2024, which the stock does not reflect, according to UBS.
The Analyst: Karl Keirstead downgraded DocuSign from Neutral to Sell, while keeping the price target unchanged at $52.
Check out other analyst stock ratings.
The Thesis: The stock has rallied around 54% from its December lows and does not appear compelling relative to other low-growth software peers, Keirstead said in the downgrade note.
“While intrigued by changes that the new CEO might make, our latest round of checks point to flattish/negative billings growth in CY23/FY24, a highly-penetrated TAM, an increasingly competitive rival in the form of Adobe, continued contract volume down-sizing risk upon renewals and a slowdown in the CLM segment,” the analyst wrote.
“We’re also cognizant that DocuSign has historically been very tied to the go-to-market engine of Salesforce, which is going through an unprecedented growth deceleration as well as internal disruption,” he added.
DOCU Price Action: Shares of DocuSign had lost 6.16% to reach $64.47 in the premarket session on Tuesday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.